Press Releases/Recent News

November 22, 2011

MABCURE RECEIVES $500,000 LICENSING FEE AS WELL AS 12.5% ONGOING ROYALTY FOR ITS PROSTATE CANCER DIAGNOSTIC TECHNOLOGY

March 8, 2011

MABCURE STUDY RESULTS ON A NEW OVARIAN CANCER DIAGNOSTIC BLOOD TEST BEING PRESENTED AT THE ANNUAL MEETING OF THE SOCIETY OF GYNECOLOGICAL ONCOLOGISTS

March 1, 2011

MABCURE INC - CORPORATE UPDATE

January 20, 2011

MABCURE SECURES $10 MILLION FUNDING COMMITMENT FROM AN INSTITUTIONAL INVESTOR MANAGED BY ROSWELL CAPITAL PARTNERS

December 6, 2010

MABCURE WELCOMES DR. CHARLES T. TACKNEY AS NEW CHIEF SCIENTIFIC OFFICER

November 8, 2010

MABCURE GENERATES TUMOR SPECIFIC ANTIBODIES AGAINST PROSTATE CANCER WHICH COULD LEAD TO A BLOOD/URINE DIAGNOSTIC TEST FOR PROSTATE CANCER

October 19, 2010

MABCURE SIGNS A COLLABORATION AGREEMENT WITH A LEADING MEDICAL CENTER IN EUROPE FOR A STUDY AIMED AT FURTHER DEVELOPMENT OF A BLOOD TEST FOR OVARIAN CANCER

August 17, 2010

THAI NATIONAL CANCER INSTITUTE JOINS MABCURE’S ONGOING STUDY IN THAILAND

August 3, 2010

MABCURE FILES PROVISIONAL PATENT IN THE U.S. FOR OVARIAN CANCER ANTIBODIES

July 27, 2010

MABCURE ANNOUNCES POSITIVE RESULTS FOR NEW OVARIAN CANCER DIAGNOSTIC BLOOD TEST

June 1, 2010

MEMORANDUM TO SHAREHOLDERS FROM DR. AMNON GONENNE, MABCURE’S CHIEF EXECUTIVE OFFICER

March 31, 2010

MABCURE CEO ARTICLE FEATURED IN THE APRIL ISSUE OF "DRUG DISCOVERY NEWS"

February 1, 2010

MABCURE FEATURED IN GENOMEWEB

January 6, 2010

MABCURE LAUNCHES CLINICAL TRIAL TO DIAGNOSE OVARIAN CANCER

November 4, 2009

MABCURE SIGNS RESEARCH AGREEMENT WITH BRUGGE, BELGIUM HOSPITAL

September 29, 2009

MABCURE PRODUCES MONOCLONAL ANTIBODIES AGAINST COLORECTAL CANCER

September 1, 2009

MABCURE CEO ARTICLE FEATURED IN THE SEPTEMBER ISSUE OF GEN®

August 25, 2009

MABCURE FEATURED IN BIOWORLD® TODAY

August 18, 2009

ARTICLE BY MABCURE CEO -- TUMOUR-SPECIFIC MARKERS: THE HOLY GRAIL OF CANCER DIAGNOSTICS

August 7, 2009

MABCURE APPEARS IN ARTICLE ON "THE USE OF BIOMOLECULES IN DIAGNOSTIC TESTING

May 28, 2009

[Video] PRESIDENT & CEO OF MABCURE, DR. AMNON GONENNE, TALKS ABOUT MABCURE AND ITS TECHONOLGY

April 27, 2009

MABCURE WELCOMES DR. DAVID S. FRANK AS NEW MEMBER OF THE BOARD OF DIRECTORS

April 1, 2009

MABCURE ESTABLISHES RESEARCH FACILITIES ON THE CAMPUS OF HASSELT UNIVERSITY

October 30th, 2008

MABCURE ESTABLISHES BELGIAN SUBSIDIARY AND RELOCATES HEADQUARTERS TO BELGIUM

July 11th, 2008

MABCURE COMPLETES KEY ACQUISITION

June 27th, 2008

MABCURE CLOSES US $1.3 MILLION PRIVATE PLACEMENT

November 30, 2007

SMARTEC ACQUIRES TECHNOLOGY FOR DETECTING EARLY STAGE CANCERS